NPS Jumps on Earnings, Gattex Sales Guidance
By Catherine Shaffer
Friday, August 9, 2013
NPS Pharmaceuticals Inc., of Bedminster, N.J., racked up $4.8 million in Gattex (teduglutide) sales in the second quarter of 2013, with expectations of $25 million to $30 million in net sales for the full year.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.